Novartis, Sandoz recall 12 medications over packaging concerns

Certain lots of Zofran ODT are included in the recall due to packing that does not meet federal childproofing standards.

Story highlights

  • The blister packaging does not meet US federal requirements for child resistance
  • Patients should immediately safeguard the blister card packages and remove them from sight and reach of children

(CNN)Twelve medicines have been recalled in the United States by Sandoz Inc. and its affiliate Novartis Pharmaceuticals Corp., the companies said in a statement Friday, because their blister packaging does not meet US federal requirements for child resistance.

There are no quality or safety issues with the recalled medicines, and patients should continue to use them as prescribed, the companies said.
Recalled products include certain lots of risperidone ODT, donepezil ODT, naratriptan, ondansetron ODT, ondansetron tablets and Zofran ODT (ondansetron) in blister card packages. Additionally, azithromycin, haloperidol, imipramine, ISDN (isosorbide dinitrate), perphenazine and Entresto (sacubitril/valsartan) in hospital unit dose blister packaging have been recalled.
    They are all prescription medications that were sold nationwide at clinics and pharmacies between September 2016 and June 2018, according to the US Consumer Product Safety Commission.
    There has been one report of a child ingesting haloperidol from a blister pack, CPSC said in announcing the recall.
    Products dispensed in bottles are not affected by this recall, according to the statement.
    Patients should immediately safeguard the blister card packages and remove them from the sight and reach of children, the companies said. For additional help or information, patients can c